Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Evogene Ltd. (EVGN) had Weighted-Average Shares Outstanding (Diluted) of 5.70M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$1.61M |
|
$0.43M |
|
$0.76M |
|
$0.86M |
|
$6.18M |
|
$-4.57M |
|
$4.57M |
|
$0.00M |
|
$0.00M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-4.57M |
|
$-3.64M |
|
5.70M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
5.70M |
$0.28 |
|
$0.28 |
|
| Balance Sheet Financials | |
$21.59M |
|
$1.80M |
|
$18.27M |
|
$39.86M |
|
$18.70M |
|
-- |
|
$6.33M |
|
$25.03M |
|
$14.84M |
|
$2.64M |
|
$14.84M |
|
6.51M |
|
| Cash Flow Statement Financials | |
$-19.70M |
|
$9.62M |
|
$4.66M |
|
$20.77M |
|
$15.30M |
|
$-5.47M |
|
$1.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
53.13% |
|
-283.49% |
|
-283.49% |
|
-- |
|
0.12% |
|
26.51% |
|
$-20.27M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.42 |
|
0.51 |
|
176.26 |
|
-0.03% |
|
-0.19% |
|
-0.01% |
|
-0.03% |
|
$2.28 |
|
$-3.56 |
|
$-3.46 |
|